Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Cyproterone acetate therapy improved hair loss and reduced testosterone levels in a menopausal woman.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

Finasteride helps reduce hidradenitis suppurativa symptoms in females.

Flibanserin's effectiveness for low sexual desire in premenopausal women may vary based on hormone levels, with normal hormone levels showing better responses.

Oocyte retrieval is possible for transgender men on testosterone therapy without affecting fertility outcomes.

Facial feminization surgery helps make facial features more feminine, improving patient satisfaction and safety.

Hirsutism and alopecia during menopause can be diagnosed and treated with specific hormonal and topical therapies.

Hormonal therapies can improve skin issues by adjusting hormone levels, with future advancements promising better results.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

A combination of desogestrel and ethinyl oestradiol effectively reduces hair growth in hirsute women.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Hirsutism treatment should focus more on patient needs and quality of life.

The document concludes that antiandrogenic drugs like cyproterone acetate and spironolactone are effective but not permanent treatments for skin-related androgenization in women.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

Hormonal therapy is a good option for women with severe acne, especially when there's a chance of hormone imbalance.

Hormonal therapy like cyproterone acetate and spironolactone may help female hair loss, but more research is needed, especially for pre-menopausal women.

Masculinization in affected individuals occurs gradually after puberty due to hormone changes.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

Hormonal therapy is effective for treating acne in adult women, especially with signs of high androgen levels.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

5α-reductase deficiency can cause ambiguous genitalia and gender dysphoria, treatable with testosterone.

Finasteride helps treat hair loss and prostate issues by blocking a hormone.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Hair loss in women can be treated with hormone therapy.

Managing menopause symptoms like skin changes and hair thinning involves hormone therapy, procedures, and skincare, with emotional support being important.

Hirsutism is managed by assessing testosterone levels and using oral contraceptives, with ethical considerations on treatment access.